Clinical trials in Corona (Covid-19) time. [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2020-03-29 05:15 (413 d 16:12 ago) – Posting: # 21305
Views: 1,543

(edited by wienui on 2020-03-29 05:30)

Hello,

EMA released on Wednesday a new draft guideline for 4-week public consultation on points that clinical trial sponsors should consider on the implications of the coronavirus disease (Covid-19) on methodological aspects of ongoing trials.

https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf

https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf

Cheers,
Osama

Complete thread:

Activity
 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 18 (0 registered, 18 guests [including 15 identified bots]).
Forum time: Sunday 21:28 UTC (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5